|Company Name||Last Price||%
|Dr Reddys Labs||2402.85||-0.04||2545.00||1764.00||40,872.41|
|Sep' 13||Jun' 13||Mar' 13||Dec' 12|
|Scheme||No. of Shares|
|Reliance Equity Opportunities Fund - Retail Plan (G)||2,527,582|
|Reliance Growth Fund - Retail Plan (G)||1,595,891|
|Reliance Regular Savings Fund - Equity Option (G)||910,592|
|ICICI Prudential Dynamic Plan (G)||728,285|
Divis Labs is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 14,708.29 crore.The company has reported a consolidated sales of Rs 657.50 crore and a Net Profit of Rs 180.57 crore for the quarter ended Mar 2013.
The company management includes Murali K Divi - Chairman & Managing Director, N V Ramana - Executive Director, Madhusudana Rao Divi - Director - Projects, Kiran S Divi - President & Director, K Satyanarayana - Director, S Vasudev - Director, G Suresh Kumar - Director.
It is listed on the BSE with a BSE Code of 532488 and the NSE with an NSE Code of DIVISLAB.
Its Registered office is at 7-1-77/E/1/303, Divi Towers,,Dharam Karan Road, Hyderabad,Andhra Pradesh - 500016.
Their Registrars are Karvy Computershare Private Ltd.